How Bausch + Lomb's $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors [Yahoo! Finance]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Yahoo! Finance
Analyst upgrades citing a strong ophthalmology pipeline and improving efficiency have sharpened investor focus on how Bausch + Lomb is reshaping its balance sheet and growth profile. We'll now examine how enthusiasm around Bausch + Lomb's ophthalmology pipeline influences the company's broader investment narrative following the latest financing move. These 11 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs . Discover why before your portfolio feels the trade war pinch. To own Bausch + Lomb, you really have to believe that a focused eyecare business with a deep ophthalmology pipeline can eventually turn steady mid-single-digit revenue growth into durable profitability, despite a history of net losses. The recent US$2.80 billions term loan refinancing tightens that story around balance sheet repair rather than transforming near term fundamentals: lower interest margins and a longer debt runway may modestly ease pressure on cash
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb: I Need To See Stability Before Upgrading This Name [Seeking Alpha]Seeking Alpha
- Bausch + Lomb Announces Refinancing of Outstanding Term B Loans [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Refinancing of Outstanding Term B LoansBusiness Wire
- Why Bausch + Lomb (BLCO) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb (NYSE:BLCO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
BLCO
Earnings
- 10/29/25 - Beat
BLCO
Sec Filings
- 12/12/25 - Form 8-K
- 11/18/25 - Form 4
- 11/18/25 - Form 4
- BLCO's page on the SEC website